Thus, as a potential strategy to counteract the loss of CD19 on leukemia cells, they generated T cells expressing both a CD19-specific CAR and a CD123-specific CAR [35] using stable lentiviral transfection to transfer both receptors into the same T cell. This evidence concerns the gene CD19 and leukemia.